返回首页
  • [肺癌消融适应症] 肺癌热消融适应症 日期:2020-03-03 21:12:25 点击:155 好评:0

    Patient Selection Criteria Clinical indications Lung Cancer Patient Characteristics High Risk Limited Recurrence Cyto-reduction Local Control Refractory Patient Refusal Patient Characteristics ACOSOG z4033 High Risk Limited Recurrence Cyto...

  • [Bottom Line] 肺癌消融:bottom line 日期:2020-03-03 19:01:23 点击:199 好评:0

    RFA of Medically Inoperable Lung Cancer: is Less More? 简单的东西往往带给人们的是更多的享受 SBRT provides better local control over 3-5 sessions c/w single RFA session SBRT still requires needle biopsy and sometimes fiducialmarkers to be pl...

  • [肺癌治疗的医学经济] 肺癌治疗:医学经济学 日期:2020-03-03 18:52:48 点击:171 好评:0

    Comparison costs from 1983-1997...

  • [随机试验] Randomized trial necessary 日期:2020-03-03 18:22:44 点击:166 好评:0

    Treatment of Stage I NSCLC Surgical resection Image guided ablation SBRT 5 year OS 60-70% 5-year OS 30- ??% 2/3 patients Randomized Trial is Necessary...

  • [RFA+放疗] 肺癌:射频消融+放疗 日期:2020-03-03 17:54:01 点击:104 好评:0

    Department of Diagnostic Imaging, Brown University Medical School, Rhode Island Hospital,...

  • [3的CRT vs RFA] 肺癌射频消融:三维适形放疗 vs 射频消融 日期:2020-03-03 16:52:09 点击:64 好评:0

    Medically Inoperable Stage I NSCLC: RF Ablation vs 3D-CRT Treatment, study, year Survival 1yr 2yr 3yr RF Ablation, RAPTUREclincal trial 2007 Overall survival 71% NA Cancer-specific survival 92% 92% NA 3D-CRT, Bradley et al, IJROBP 2003 Ove...

  • [SBRT] SBRT 体部立体定向放疗 日期:2020-03-03 16:46:47 点击:80 好评:0

    SBRT Stereotactic Body Radiotherapy 体部立体定向放疗 http://www.morsecyberknife.com/procedure-cyberberknife.htm Accuray Cyberknife XRay based SBRT Trilogy-Cone Beam-CTbased SBRT...

  • [复发对策] 肺癌射频消融:复发的的讨论 日期:2020-03-03 12:41:41 点击:171 好评:0

    Recurrence after RFA Brown university Experience To review the recurrence patterns in patients with primary non-small cell lung cancer (NSCLC) treated with percutaneous image-guided radiofrequency (RF) ablation. The most common pattern of...

  • [不同治疗方式选择的比较] 肺癌不同治疗模式生存比较 日期:2020-03-02 23:57:26 点击:74 好评:0

    Alla Y. Zemlyak, MD Comparison of survival after sublobar resections and ablative therapies for stage I NSCLC Primary end points overall survival, cancer-specific survival, and cancer-free survival N=25 SLR N=12 RFA N=27 Cryo N= CECT, FDG...

  • [分期] 肺癌射频消融:分期比较 日期:2020-03-02 23:38:12 点击:146 好评:0

    RF Ablation of Medically Inoperable Stage I NSCLC Simon et al, Radiology 2007...